Global Clinical Packaging Organization

Small Pharma, Big Studies.

Xerimis is uniquely positioned to service the specific needs of small to mid-sized pharmaceutical companies. We know that the task of a modern day clinical packaging organization demands excellence in two key areas: an industry-leading knowledge of the landscape and its complexities along with a tireless dedication to client needs. At Xerimis, we understand the unique demands of your project, and we're here, alongside you, every step of the way.

Phase One

Phase I trials are the building blocks needed for all successful drug compounds. We work with our clients to develop the most user friendly designs to help ensure that the right drug is dispensed correctly at the right time.

Xerimis plus Xerimis plus Learn More About Phase One
Packaging Consultation
On Demand Labeling
Just-in-time Shipping
Fast Turnaround

Phase Two

Phase 2 trials bring more complexity and critical packaging decisions to the clinical development team. You can rely on Xerimis to help guide you through this process.

Xerimis plus Xerimis plus Learn More About Phase Two
Blinding Services
Protocol Specific Labeling
Pooled IDP/IMP Supply Chain Management
Procurement of Ancillary Supplies

Phase Three

Phase 3 trials typically draw on a large number of global sites to fill the enrollment needs of the study. Xerimis has extensive experience with global Phase 3 trials.

Xerimis plus Xerimis plus Learn More About Phase Three
Packaging Supply Management
Translation Services
IWRS/IVRS Consultation
Supply Chain Management
Depot Management

The path through a trial is complicated.
Let us make it easy for you.

Xerimis plus Xerimis plus Get Started

Agile Ability with Global Reach.

The benefits of an international player with the agility of something much more personal

Xerimis, US (HQ)
Xerimis, UK
Xerimis, Netherlands

Real-time Data.
From Anywhere.

We're constantly striving to provide our clients with a better, more comprehensive experience, and DashX is our latest evolution in fulfilling on that promise.

Xerimis plus Xerimis plus Register for a Free Test-drive

Insights & News

Thank you to our team and our vendors

As we continue to monitor the Covid-19 virus and its impacts, I wanted to take a moment to extend a thank you to our team and our vendors.

blue-plus Continue Reading

Covid-19 update: Vital Operations continue at Xerimis

On Saturday, March 21st, the Governor of New Jersey issued an Executive Order No. 107 requiring all Non-Essential Retail Businesses to close.  Xerimis is not forcedto close our business since Xerimis is part of the pharmaceutical supply chain responsible for providing medicines to patients, and as such is considered in the category defined as Healthcare/Life Sustaining businesses.

blue-plus Continue Reading

Xerimis Coronavirus Planning Measures

Xerimis is committed to the safety of our clients, patients, and own team members while we continue to ensure that your clinical supplies are packaged, dispatched and delivered with minimal disruption.

blue-plus Continue Reading